Sun Pharma stock has gained 5.88 per cent in a year and fallen 2.29 percent in 2023. A total of 0.52 lakh shares of the firm changed hands amounting to a turnover of Rs 5.08 crore on BSE.
"US FDA has directed the Company to take certain corrective actions at the Mohali facility before releasing further final product batches into the US," the company said.
The USFDA has assigned the inspection classification of the API facility as Voluntary Action Indicated pursuant to its inspection at the API manufacturing facility of Jubilant Pharmova Ltd at Nanjangud during 05-13 December 2022.
By Dan Levine and Marisa Taylor (Reuters) - U.S. drug inspectors recently recorded several new quality- control problems at an Eli Lilly and Co plant .
U.S. drug inspectors recently recorded several new quality- control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.